These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38810936)

  • 1. Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection.
    Cho Y; Park K; Park J; An J; Myung H; Yoon H
    Int J Antimicrob Agents; 2024 Aug; 64(2):107222. PubMed ID: 38810936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage endolysins as a potential weapon to combat
    Mondal SI; Draper LA; Ross RP; Hill C
    Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range.
    Mayer MJ; Garefalaki V; Spoerl R; Narbad A; Meijers R
    J Bacteriol; 2011 Oct; 193(19):5477-86. PubMed ID: 21803993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection.
    Phothichaisri W; Chankhamhaengdecha S; Janvilisri T; Nuadthaisong J; Phetruen T; Fagan RP; Chanarat S
    Microbiol Spectr; 2022 Apr; 10(2):e0236121. PubMed ID: 35377223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin.
    Mayer MJ; Narbad A; Gasson MJ
    J Bacteriol; 2008 Oct; 190(20):6734-40. PubMed ID: 18708505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD27L and CTP1L endolysins targeting Clostridia contain a built-in trigger and release factor.
    Dunne M; Mertens HD; Garefalaki V; Jeffries CM; Thompson A; Lemke EA; Svergun DI; Mayer MJ; Narbad A; Meijers R
    PLoS Pathog; 2014 Jul; 10(7):e1004228. PubMed ID: 25058163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an Endolysin Targeting
    Mondal SI; Akter A; Draper LA; Ross RP; Hill C
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073633
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring novel microbial metabolites and drugs for inhibiting
    Abouelkhair AA; Seleem MN
    mSphere; 2024 Jul; 9(7):e0027324. PubMed ID: 38940508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor.
    Whittle MJ; Bilverstone TW; van Esveld RJ; Lücke AC; Lister MM; Kuehne SA; Minton NP
    Microbiol Spectr; 2022 Feb; 10(1):e0229521. PubMed ID: 35107319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of live biotherapeutics against
    Zhang Y; Saint Fleur A; Feng H
    Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatment approaches for
    Bratkovič T; Zahirović A; Bizjak M; Rupnik M; Štrukelj B; Berlec A
    Gut Microbes; 2024; 16(1):2337312. PubMed ID: 38591915
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.